SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2018-08-03
Tx date 2018-08-01 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-35,400
-236,000 vol
$0.15 each 		1,307,250
Filed 2017-12-15
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-20,500
-50,000 vol
$0.41 each 		1,643,250
Filed 2017-12-15
Tx date 2017-12-13 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-70,000
-100,000 vol
$0.70 each 		1,543,250
Filed 2017-12-15
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,000
-50,000 vol
$0.46 each 		1,693,250
Filed 2017-11-08
Tx date 2017-11-06 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-18,275
-107,500 vol
$0.17 each 		1,743,250
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Options
50 - Grant of options
+200,000 vol 		200,000
Filed 2017-09-12
Tx date 2015-09-16 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-11 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-6,750
-45,000 vol
$0.15 each 		36,159
Filed 2017-08-23
Tx date 2015-09-16 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-23
Tx date 2017-08-21 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Holder: Jim Irving Consulting (Indirect Ownership)
Common Shares
46 - Compensation for services 		$6,995
+81,159 vol
$0.0862 each 		81,159
Filed 2017-06-21
Tx date 2017-06-15 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$-48,000
-300,000 vol
$0.16 each 		1,850,750
Filed 2017-06-15
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		2,150,750
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		1,650,750
Filed 2017-04-15
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$75,000
+500,000 vol
$0.15 each
Filed 2017-04-15
Tx date 2017-03-30 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,450
-45,000 vol
$0.21 each
Filed 2017-04-15
Tx date 2017-03-30 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,675
-45,000 vol
$0.215 each 		705,750
Filed 2017-04-15
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$93,000
+600,000 vol
$0.155 each 		1,150,750
Filed 2017-04-10
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$75,000
+500,000 vol
$0.15 each 		1,050,750
Filed 2017-04-03
Tx date 2017-03-31 		$ATT
Abattis Bioceuticals Corp. 		Irving, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-31,000
-155,000 vol
$0.20 each 		550,750